Nantahala Capital Management, LLC Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$3.5T
Holdings
116
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (116 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —HTG MOLECULAR DIAGNOSTICS IN | 363,622 | $2.1B | 0.06% | |
| 102 | —5 01 ACQUISITION CORP | 186,650 | $1.9B | 0.05% | |
| 103 | —ANGION BIOMEDICA CORP | 125,000 | $1.6B | 0.05% | |
| 104 | —TELIGENT INC NEW | 2,418,987 | $1.3B | 0.04% | |
| 105 | —METROMILE INC | 558,296 | $1.2B | 0.04% | |
| 106 | —KINTARA THERAPEUTICS INC | 523,279 | $1.2B | 0.03% | |
| 107 | —SUSTAINABLE OPPORTNTS ACQ CO | 802,758 | $1.2B | 0.03% | |
| 108 | —PERELLA WEINBERG PARTNERS | 400,000 | $1.1B | 0.03% | |
| 109 | PAYOPAYONEER GLOBAL INC | 333,327 | $790.0M | 0.02% | |
| 110 | IMTXIMMATICS N.V | 226,471 | $779.0M | 0.02% | |
| 111 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 50,000 | $773.0M | 0.02% | |
| 112 | —CYREN LTD | 598,540 | $485.0M | 0.01% | |
| 113 | MDIAMEDIACO HLDG INC | 103,680 | $373.0M | 0.01% | |
| 114 | SIGASIGA TECHNOLOGIES INC | 49,605 | $312.0M | 0.01% | |
| 115 | —FALCON MINERALS CORP | 878,022 | $167.0M | 0.00% | |
| 116 | —AVENUE THERAPEUTICS INC | 30,211 | $76.0M | 0.00% |
PreviousPage 2 of 2